Morgan Stanley Inogen Inc Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Inogen Inc stock. As of the latest transaction made, Morgan Stanley holds 531,290 shares of INGN stock, worth $3.35 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
531,290
Previous 472,288
12.49%
Holding current value
$3.35 Million
Previous $4.33 Million
12.52%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding INGN
# of Institutions
140Shares Held
19.6MCall Options Held
19.3KPut Options Held
11.3K-
Black Rock Inc. New York, NY1.63MShares$10.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.54MShares$9.71 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.03MShares$6.48 Million0.02% of portfolio
-
Kent Lake Pr LLC Anasco, PR1MShares$6.32 Million3.3% of portfolio
-
Camber Capital Management LP Boston, MA975KShares$6.14 Million0.26% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $144M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...